Amarin Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives
Amarin to Present at the 33rd Annual J.P. Morgan Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015
Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl) in China Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl) in China
Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, March 3, 2015 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, March 3, 2015
Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations
New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit
Amarin Announces $52.8 Million Private Placement Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces $52.8 Million Private Placement
New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other Triglyceride Lowering Agents Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other Triglyceride Lowering Agents
Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts
